Joachim-Friedrich Kapp
Direktor/Vorstandsmitglied bei Sartorius CellGenix GmbH
Profil
Joachim-Friedrich Kapp is currently a Member-Supervisory Board at Sartorius CellGenix GmbH.
Previously, he held positions as a Director at Titan Pharmaceuticals, Inc. from 2005 to 2010, a Director at Bayer Pharma AG, a Director-Clinical Development at Genelux Corp., and the President-Global Business Unit at Bayer Schering Pharma AG.
He obtained a doctorate degree from the University of Duisburg-Essen.
Aktive Positionen von Joachim-Friedrich Kapp
| Unternehmen | Position | Beginn |
|---|---|---|
Sartorius CellGenix GmbH
 Sartorius CellGenix GmbH BiotechnologyHealth Technology CellGenix GmbH provides biopharmaceutical products. Its products include CellGro Cytokines, CellGro Supplements and Cells, Bioprocessing Containers and CellGro Serum-free Media. It is supplier of GMP (Good Manufacturing Practice) manufactured cytokines and serum-free media for cell therapy applications. The company was founded in 1994 and is headquartered in Freiburg, Germany. | Direktor/Vorstandsmitglied | 18.04.2011 |
Ehemalige bekannte Positionen von Joachim-Friedrich Kapp
| Unternehmen | Position | Ende |
|---|---|---|
| TITAN PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 26.10.2010 |
Bayer Pharma AG
 Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Direktor/Vorstandsmitglied | - |
| GENELUX CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | - |
| Bayer Schering Pharma AG | Corporate Officer/Principal | - |
Ausbildung von Joachim-Friedrich Kapp
| University of Duisburg-Essen | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| TITAN PHARMACEUTICALS, INC. | Health Technology |
| GENELUX CORPORATION | Health Technology |
| Private Unternehmen | 3 |
|---|---|
| Bayer Schering Pharma AG | Health Technology |
Bayer Pharma AG
Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Health Technology |
Sartorius CellGenix GmbH
Sartorius CellGenix GmbH BiotechnologyHealth Technology CellGenix GmbH provides biopharmaceutical products. Its products include CellGro Cytokines, CellGro Supplements and Cells, Bioprocessing Containers and CellGro Serum-free Media. It is supplier of GMP (Good Manufacturing Practice) manufactured cytokines and serum-free media for cell therapy applications. The company was founded in 1994 and is headquartered in Freiburg, Germany. | Health Technology |
